PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1882989
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1882989
Bioresorbable Coronary Stents Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of bioresorbable coronary stents Market
The global bioresorbable coronary stents market is witnessing steady expansion as the demand for advanced cardiovascular treatments increases worldwide. According to the latest market data, the global market size reached USD 340.5 million in 2024, is projected to grow to USD 356.0 million in 2025, and is expected to rise significantly to USD 520.4 million by 2032, reflecting a CAGR of 5.6% during the forecast period. North America dominated the global market in 2024, accounting for 38.59% of the total share owing to its strong healthcare infrastructure and high coronary intervention volume.
Bioresorbable coronary stents-also called scaffolds-are designed to gradually dissolve after opening blocked arteries, eliminating the long-term complications associated with permanent metallic implants. Made primarily from advanced polymers or biodegradable metals, these devices provide temporary mechanical support before safely degrading inside the body. Their ability to restore natural vasomotion and reduce the risk of late stent thrombosis has contributed significantly to rising adoption.
Market Drivers
The key driver of market growth is the increasing global prevalence of coronary artery disease (CAD). Lifestyle-related factors such as rising alcohol consumption, smoking, physical inactivity, and chronic stress are causing a surge in cardiac cases. For example, the CDC reported in October 2024 that nearly 1 in 20 U.S. adults aged 20+ suffered from CAD in 2023, highlighting the critical need for effective treatments. As aging populations expand worldwide, the number of patients requiring minimally invasive cardiology procedures continues to rise. Bioresorbable stents offer several clinical advantages, such as reduced long-term complications and restored vascular function, strengthening their demand in both developed and developing healthcare markets.
Market Restraints
Despite their benefits, bioresorbable coronary stents face strong competition from drug-eluting stents (DES) and metallic stents, which are well-established, cost-effective, and backed by extensive clinical data. While early results for bioresorbable devices are promising, more long-term evidence is needed to validate their safety and performance. Additionally, uncertainties regarding restenosis and long-term vessel healing remain concerns among clinicians, potentially slowing widespread adoption.
Market Opportunities
Significant growth opportunities are emerging in developing regions, driven by improving healthcare infrastructure and rising public awareness of cardiac diseases. Government-led initiatives, such as the Indian Ministry of Health's heart health campaign in September 2023, are helping educate patients about treatment options, including advanced stenting procedures. Hospitals worldwide are also expanding cardiology services. For instance, Canberra Hospital in Australia launched a new critical services building in August 2024 to expand cardiovascular intervention capabilities, supporting greater demand for bioresorbable stents.
Market Challenges
A major challenge in the market is the high cost of bioresorbable coronary stents, driven by advanced biomaterials and complex manufacturing processes. As of June 2025, BVS treatment in India ranged from USD 2,500-5,000, limiting affordability in low- and middle-income countries. Furthermore, companies must invest heavily in clinical trials and regulatory compliance, slowing product availability and market penetration.
Key Market Trends
Innovation remains central to market growth. Manufacturers are investing in new material technologies, enhanced drug-eluting capabilities, and improved stent designs. The launch of next-generation magnesium scaffolds, such as BIOTRONIK's Freesolve evaluated in the BIOMAG-II trial in May 2024, highlights significant progress. Hybrid stent designs and biosensor-integrated stents are emerging as future solutions, offering real-time monitoring and personalized treatment.
Regional Insights
North America
North America led the market in 2024 with USD 131.4 million in value. Strong CAD prevalence and increased adoption of minimally invasive procedures are driving regional demand.
Europe
Europe held the second-largest share, supported by rising obesity rates and strong product introductions. In England alone, 25.6% of adults were reported obese between 2021-2022.
Asia Pacific
Asia Pacific ranked third in 2024, driven by high smoking rates, stressful lifestyles, and increased stent placements. Stent treatment cases increased from 13.8% in 2019 to 19.4% in 2021.
Latin America & Middle East & Africa
These regions continue to grow due to rising hypertension, diabetes, and lifestyle-related risks.
Conclusion
With the market increasing from USD 340.5 million in 2024 to USD 356.0 million in 2025, and projected to reach USD 520.4 million by 2032, the bioresorbable coronary stents market is positioned for sustained growth. Advances in biomaterials, rising cardiovascular cases, and global expansion of cardiology services will continue to shape the industry's trajectory.
Segmentation By Application
- Acute Coronary Syndrome (ACS)
- Chronic Coronary Syndrome (CCS)
By End-user
- Hospitals & ASCs
- Specialty Clinics
- Others
By Geography
- North America (By Material, Application, End-user, and Country/Sub-region)
- U.S.
- Canada
- Europe (By Material, Application, End-user, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Material, Application, End-user, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Material, Application, End-user, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Material, Application, End-user, and Country/Sub-region)
- GCC
- South Africa
- Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Incidence of Key Diseases, By Key Countries/Regions, 2023/2024
- 4.2. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
- 4.3. Technological Advancements in the Bioresorbable Coronary Stents
- 4.4. New Product Launches
- 4.5. Reimbursement Scenario for Key Procedures
5. Global Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast - By Material
- 5.1.1. Metal
- 5.1.2. Polymer
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Acute Coronary Syndrome (ACS)
- 5.2.2. Chronic Coronary Syndrome (CCS)
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospitals & ASCs
- 5.3.2. Specialty Clinics
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast - By Material
- 6.1.1. Metal
- 6.1.2. Polymer
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Acute Coronary Syndrome (ACS)
- 6.2.2. Chronic Coronary Syndrome (CCS)
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospitals & ASCs
- 6.3.2. Specialty Clinics
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast - By Material
- 7.1.1. Metal
- 7.1.2. Polymer
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Acute Coronary Syndrome (ACS)
- 7.2.2. Chronic Coronary Syndrome (CCS)
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospitals & ASCs
- 7.3.2. Specialty Clinics
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia Pacific Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast - By Material
- 8.1.1. Metal
- 8.1.2. Polymer
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Acute Coronary Syndrome (ACS)
- 8.2.2. Chronic Coronary Syndrome (CCS)
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospitals & ASCs
- 8.3.2. Specialty Clinics
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast - By Material
- 9.1.1. Metal
- 9.1.2. Polymer
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Acute Coronary Syndrome (ACS)
- 9.2.2. Chronic Coronary Syndrome (CCS)
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospitals & ASCs
- 9.3.2. Specialty Clinics
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast - By Material
- 10.1.1. Metal
- 10.1.2. Polymer
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Acute Coronary Syndrome (ACS)
- 10.2.2. Chronic Coronary Syndrome (CCS)
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospitals & ASCs
- 10.3.2. Specialty Clinics
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles
- 11.2.1. Boston Scientific Corporation
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Terumo Corporation
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Relisys Medical Devices Limited
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. MicroPort Scientific Corporation
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Lepu Medical
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Elixir Medical
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. SINOMED
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Reva Medical, LLC.
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. ELLA - CS, s.r.o
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.1. Boston Scientific Corporation
List of Tables
- Table 1: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
- Table 2: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
- Table 3: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
- Table 4: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Region, 2019-2032
- Table 5: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
- Table 6: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
- Table 7: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
- Table 8: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country, 2019-2032
- Table 9: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
- Table 10: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
- Table 11: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
- Table 12: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
- Table 13: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
- Table 14: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
- Table 15: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
- Table 16: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
- Table 17: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
- Table 18: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
- Table 19: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
- Table 20: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
- Table 21: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
- Table 22: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
- Table 23: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
- Table 24: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
List of Figures
- Figure 1: Global Bioresorbable Coronary Stents Market Revenue Breakdown (USD million, %) by Region, 2024 & 2032
- Figure 2: Global Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024 & 2032
- Figure 3: Global Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024 & 2032
- Figure 4: Global Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024 & 2032
- Figure 5: Global Bioresorbable Coronary Stents Market Value (USD million), by Region, 2024 & 2032
- Figure 6: North America Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
- Figure 7: North America Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
- Figure 8: North America Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
- Figure 9: North America Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
- Figure 10: North America Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
- Figure 11: North America Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
- Figure 12: North America Bioresorbable Coronary Stents Market Value (USD million), By Country, 2024 & 2032
- Figure 13: North America Bioresorbable Coronary Stents Market Value Share (%), By Country, 2024
- Figure 14: Europe Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
- Figure 15: Europe Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
- Figure 16: Europe Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
- Figure 17: Europe Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
- Figure 18: Europe Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
- Figure 19: Europe Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
- Figure 20: Europe Bioresorbable Coronary Stents Market Value (USD million), By Country/Sub-region, 2024 & 2032
- Figure 21: Europe Bioresorbable Coronary Stents Market Value Share (%), By Country/Sub-region, 2024
- Figure 22: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
- Figure 23: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
- Figure 24: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
- Figure 25: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
- Figure 26: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
- Figure 27: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
- Figure 28: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
- Figure 29: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
- Figure 30: Latin America Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
- Figure 31: Latin America Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
- Figure 32: Latin America Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
- Figure 33: Latin America Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
- Figure 34: Latin America Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
- Figure 35: Latin America Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
- Figure 36: Latin America Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
- Figure 37: Latin America Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
- Figure 38: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
- Figure 39: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
- Figure 40: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
- Figure 41: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
- Figure 42: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
- Figure 43: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
- Figure 44: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
- Figure 45: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
- Figure 46: Global Bioresorbable Coronary Stents Market Share (%), By Company, 2024
